Long-Term Efficacy and Toxicity of Low-Dose-Rate 125 I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer
- 1 July 2015
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 92 (4), 884-893
- https://doi.org/10.1016/j.ijrobp.2015.02.047
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- 15-Year Cause Specific and All-Cause Survival Following Brachytherapy for Prostate Cancer: Negative Impact of Long-Term Hormonal TherapyJournal of Urology, 2014
- Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-Year experience at Mount Sinai Medical CenterUrologic Oncology, 2014
- Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancerCancer, 2012
- Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experienceBrachytherapy, 2012
- 10-Year Experience With I-125 Prostate Brachytherapy at the Princess Margaret Hospital: Results for 1,100 PatientsInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Long-Term Outcome for Clinically Localized Prostate Cancer Treated With Permanent Interstitial BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Prostate CancerJournal of the National Comprehensive Cancer Network, 2010
- Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantationInternational Journal of Radiation Oncology*Biology*Physics, 2007
- 12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987